D anti-mCD45.2 mAbs, and APC-conjugated anti-mCD45.1 mAbs (all from BD Biosciences) were used to analyze Docosahexaenoyl ethanolamide Mo-NOG mice. Flow Madecassoside price cytometric analysis was conducted using the FACSCanto II (BD Biosciences) system. A total of 10,000 events were analyzed for each sample. FlowJo software (TreeStar, Ashland, OR) was used for the analysis of flowIn Vivo Tool for Assessing Hematotoxicity in HumanFigure 3. Establishment of hematopoietic cell lineages in NOG mice. Flow cytometric analysis of leukocytes in the peripheral blood and hematopoietic organs of untreated Hu-NOG (A) and Mo-NOG (B) mice. Rates of leukocyte chimerism in Hu-NOG mice were calculated as the percentage of hCD45+mCD452 cells in the total CD45+ cell population (the sum of human and mouse CD45+ cells). Data represent the mean 6 standard deviation (SD; n = 7 or n = 8). Rates of leukocyte chimerism in Mo-NOG mice were calculated as the percentage of mCD45.2+mCD45.12 cells in the total CD45+ cell population (the sum of mCD45.1+ and mCD45.2+ cells). Data represent the mean 6 SD (n = 6?). doi:10.1371/journal.pone.0050448.gBenzene Toxicity in Human Leukocytes from Hu-NOG MiceHuman leukocytes were identified in the peripheral blood and hematopoietic organs of Hu-NOG mice by double staining with anti-hCD45 and anti-mCD45 antibodies. By maintenance of the mice for about 4.5 months after cell transplantation, human leukocytes were highly represented in leukocytes contained in all target tissues of Hu-NOG mice (Fig. 3A). The numbers of human leukocytes in Hu-NOG mice without benzene administration were 1.56107 cells/tissue (bone marrow), 3.06108 cells/tissue (spleen), 3.16105 cells/tissue (thymus) and 5.26102 cells/mL (peripheral blood). Next, we evaluated the toxic effects of benzene on human leukocytes (hCD45+mCD452) in the peripheral blood and hematopoietic organs of Hu-NOG mice. The numbers of human leukocytes in all samples were reduced depending on the amount of benzene administered to the same extent as human hematopoietic stem/progenitor cells in the bone marrow (Fig. 4A). The numbers of human leukocytes in Hu-NOG mice given 30 mg benzene/kg-b.w./day were 0.78- (bone marrow), 0.28- (spleen), 0.30- (thymus), and 0.40-fold (peripheral blood) the number inuntreated Hu-NOG mice. The number of cells decreased most drastically in the spleen. We next analyzed the population of human leukocytes in HuNOG mice using anti-hCD33 mAbs and found that benzene administration caused a more dramatic reduction in the number of lymphoid cells (hCD332) than in the number of myeloid cells (hCD33+) in the bone 1516647 marrow and peripheral blood (Fig. 4B). Initially, the spleen and thymus contained only a few myeloid cells (less than 4 of total leukocytes). The percentages of individual types of T cells in the thymus, as identified using differentiation markers, are shown in Figure 4C. The relative abundance of hCD4+hCD8+ cells was affected by benzene administration to a greater extent than the other 3 T cell populations (hCD4+hCD8+ cells constituted 70.1, 59.8, 52.1, 2.6, and 0.6 of T cells in the thymus of Hu-NOG mice after 0, 10, 30, 100, and 300 mg/kgb.w. benzene administration, respectively).Comparison of Benzene Toxicity in Hu-NOG and Mo-NOG MiceIn this study, NOG mice (CD45.1) with different strain-derived mouse hematopoietic lineages were established by transplantingIn Vivo Tool for Assessing Hematotoxicity in HumanFigure 4. Benzene toxicity in human leukocytes from Hu-NOG mice. (A) Human leukocytes collected f.D anti-mCD45.2 mAbs, and APC-conjugated anti-mCD45.1 mAbs (all from BD Biosciences) were used to analyze Mo-NOG mice. Flow cytometric analysis was conducted using the FACSCanto II (BD Biosciences) system. A total of 10,000 events were analyzed for each sample. FlowJo software (TreeStar, Ashland, OR) was used for the analysis of flowIn Vivo Tool for Assessing Hematotoxicity in HumanFigure 3. Establishment of hematopoietic cell lineages in NOG mice. Flow cytometric analysis of leukocytes in the peripheral blood and hematopoietic organs of untreated Hu-NOG (A) and Mo-NOG (B) mice. Rates of leukocyte chimerism in Hu-NOG mice were calculated as the percentage of hCD45+mCD452 cells in the total CD45+ cell population (the sum of human and mouse CD45+ cells). Data represent the mean 6 standard deviation (SD; n = 7 or n = 8). Rates of leukocyte chimerism in Mo-NOG mice were calculated as the percentage of mCD45.2+mCD45.12 cells in the total CD45+ cell population (the sum of mCD45.1+ and mCD45.2+ cells). Data represent the mean 6 SD (n = 6?). doi:10.1371/journal.pone.0050448.gBenzene Toxicity in Human Leukocytes from Hu-NOG MiceHuman leukocytes were identified in the peripheral blood and hematopoietic organs of Hu-NOG mice by double staining with anti-hCD45 and anti-mCD45 antibodies. By maintenance of the mice for about 4.5 months after cell transplantation, human leukocytes were highly represented in leukocytes contained in all target tissues of Hu-NOG mice (Fig. 3A). The numbers of human leukocytes in Hu-NOG mice without benzene administration were 1.56107 cells/tissue (bone marrow), 3.06108 cells/tissue (spleen), 3.16105 cells/tissue (thymus) and 5.26102 cells/mL (peripheral blood). Next, we evaluated the toxic effects of benzene on human leukocytes (hCD45+mCD452) in the peripheral blood and hematopoietic organs of Hu-NOG mice. The numbers of human leukocytes in all samples were reduced depending on the amount of benzene administered to the same extent as human hematopoietic stem/progenitor cells in the bone marrow (Fig. 4A). The numbers of human leukocytes in Hu-NOG mice given 30 mg benzene/kg-b.w./day were 0.78- (bone marrow), 0.28- (spleen), 0.30- (thymus), and 0.40-fold (peripheral blood) the number inuntreated Hu-NOG mice. The number of cells decreased most drastically in the spleen. We next analyzed the population of human leukocytes in HuNOG mice using anti-hCD33 mAbs and found that benzene administration caused a more dramatic reduction in the number of lymphoid cells (hCD332) than in the number of myeloid cells (hCD33+) in the bone 1516647 marrow and peripheral blood (Fig. 4B). Initially, the spleen and thymus contained only a few myeloid cells (less than 4 of total leukocytes). The percentages of individual types of T cells in the thymus, as identified using differentiation markers, are shown in Figure 4C. The relative abundance of hCD4+hCD8+ cells was affected by benzene administration to a greater extent than the other 3 T cell populations (hCD4+hCD8+ cells constituted 70.1, 59.8, 52.1, 2.6, and 0.6 of T cells in the thymus of Hu-NOG mice after 0, 10, 30, 100, and 300 mg/kgb.w. benzene administration, respectively).Comparison of Benzene Toxicity in Hu-NOG and Mo-NOG MiceIn this study, NOG mice (CD45.1) with different strain-derived mouse hematopoietic lineages were established by transplantingIn Vivo Tool for Assessing Hematotoxicity in HumanFigure 4. Benzene toxicity in human leukocytes from Hu-NOG mice. (A) Human leukocytes collected f.

D anti-mCD45.2 mAbs, and APC-conjugated anti-mCD45.1 mAbs (all from BD Biosciences

About author

Leave a reply

You must be logged in to post a comment.